Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials and Real-World Data.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yadav Chandra Prakash, Lim Laura Huey Mien, Price David, Roy Rupsa, Juang Yah Ru, Beasley Richard, Janson Christer, Koh Mariko Siyue, Wang Eileen, Wechsler Michael E, Jackson David J, Busby John, Heaney Liam G, Pfeffer Paul E, Mahboub Bassam, Perng Diahn-Warng, Cosio Borja G, Perez-de-Llano Luis, Al-Lehebi Riyad, Larenas-Linnemann Désirée, Al-Ahmad Mona, Rhee Chin Kook, Iwanaga Takashi, Heffler Enrico, Canonica Giorgio Walter, Costello Richard, Papadopoulos Nikolaos G, Papaioannou Andriana I, Porsbjerg Celeste M, Torres-Duque Carlos A, Christoff George C, Popov Todor A, Hew Mark, Peters Matthew, Gibson Peter G, Maspero Jorge, Bergeron Celine, Cerda Saraid, Contreras Elvia Angelica, Chen Wenjia
Аннотация
RESEARCH QUESTION: How do the interactive pathways of risk predictors leading to severe asthma exacerbations compare under clinical trials vs real-world settings?
STUDY DESIGN AND METHODS: The analysis involved 345 patients with severe asthma from the placebo arms of 2 international randomized controlled trials (RCTs), compared with 6,814 biologic-naïve patients from the International Severe Asthma Registry (ISAR). Sixteen key risk predictors, including demographics, biomarkers, lung function, health care use, exacerbation history, long-term oral corticosteroid use, asthma control, and nasal polyps, were covered. The outcome was the occurrence of severe asthma exacerbations over the 365 days after study enrollment. Bayesian networks (BNs), obtained from machine learning combined with expert knowledge, elucidated significant interplay processes of risk predictors that led to severe asthma exacerbations. External validation was performed in each cohort.
RESULTS: The RCTs revealed 44 significant arcs (ie, probabilistic interdependency) between 16 risk factors, whereas the ISAR showed 170. Despite this difference, the main downstream prediction pathways were consistent across both settings, with 2 key pathways: total serum IgE level influenced blood eosinophils to predict future severe exacerbations, and severe exacerbation history directly predicted future severe exacerbations. In external validation, RCT-BN generalized well to ISAR patients (area under the receiver operating characteristic curve, 0.68), whereas ISAR-BN underperformed in RCT patients (area under the receiver operating characteristic curve, 0.50), and ISAR-BN demonstrated better calibration.
INTERPRETATION: Our results show that the core pathways predicting severe asthma exacerbations were similar in both RCTs and real-world settings, with comparable predictive performance.